Multiple studies document the involvement of aberrant IGF signaling in a variety of human age-related pathologies such as osteoporosis, type II diabetes, immune aging, cancer, atherosclerosis, in addition to pulmonary fibrosis, AD, and age-related macular degeneration (AMD) that are discussed here. The gene discussed is IGF1; the disease is Alzheimer disease.